Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

7.800 +0.120 (+1.56%)
Streaming Delayed Price Updated: 1:26 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
Why Is Life Science Company NanoString Stock Trading Lower Today?
NanoString Technologies Inc (NASDAQ: NSTG) shares are trading lower after a jury in the U.S. 
Via Benzinga
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
Via Benzinga
Cathie Wood's Ark Invest Purchases $9.5M Worth Of Robinhood Shares, Downsizes Holdings Of Grayscale Bitcoin Investment Trust
Via Benzinga
Cathie Wood's Ark Invest Scoops Up More Than $3M Worth Of SoFi Technologies Shares Amid Q3 Earnings Beat From Online Lender
Via Benzinga
Topics Earnings
Exposures Financial
Where 10x Genomics Stands With Analysts
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Earnings Outlook For 10x Genomics
Via Benzinga
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
Where 10x Genomics Stands With Analysts
Via Benzinga
Looking Into 10x Genomics's Return On Capital Employed
Via Benzinga
Cathie Wood's Ark Offloads $6.3M In Tesla Shares Amid EV Maker's Q3 Earnings Disappointment
Via Benzinga
Elliott Wave Technical Analysis: 10x Genomics Inc. Thursday, September 28
We have been correcting as forecasted, after what seems to be a five wave move to the upside in either wave (1) or (A). Looking for a corrective wave to then resume higher. 
Via Talk Markets
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
Buy-Zone-Adjacent 10x Genomics Tops Sales Views, But There's A Caveat
The company is working in the nascent research area of spatial biology, which could unlock the answers to some diseases. 
Via Investor's Business Daily
10x Genomics Inc. (NASDAQ: TXG) Sets New 52-Week High in Thursday Session
Via Investor Brand Network
7 Analysts Have This to Say About 10x Genomics
Via Benzinga
10x Genomics: Q1 Earnings Insights
Via Benzinga
Earnings Preview: 10x Genomics
Via Benzinga
Elliott Wave Technical Analysis:10X Genomics Inc.
Looking for short-term shorts as we should start to unfold lower. ​​​​​​ 
Via Talk Markets
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
Amazon, ELF and CAT were earnings winners, but there were big losers too. 
Via Investor's Business Daily
Brace for Impact: These 5 Overvalued Stocks Face Bearish Pressure In Impending Market Reversal
Via Benzinga
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock. 
Via InvestorPlace
Analyst Expectations for 10x Genomics's Future
Via Benzinga
Elliott Wave Technical Analysis: 10x Genomics
Looking for upside resumption soon or else the count will be invalidated. 
Via Talk Markets
Why Are NanoString Technologies Shares Falling Today
Wednesday, 10x Genomics Inc (NASDAQ: TXG) won an injunction in its patent litigation against NanoString Technologies Inc (NASDAQ: NSTG) and its German subsidiary regarding CosMx  
Via Benzinga
Why Shares of NanoString Technologies Are Falling Thursday
The company lost a patent ruling in Germany to life sciences competitor 10x Genomics. 
Via The Motley Fool
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback